HGSI

AcronymDefinition
HGSIHuman Genome Sciences, Inc. (Rockville, MD)
HGSIHuman Genome Sequencing Index (Human Genome Project tracking)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
A global digital agency, HGSi provides global brands an array of 360 degree digital solutions including digital marketing, social CRM and web/ mobile apps to several marquee clients in CPG, hospitality, BFSI and ecommerce sectors.
(11) In the end, Grace donated the land to HGSI, thereby eliminating its costs, locking VVL out of Virginia, improving its public relations, (12) and claiming charitable tax deductions.
This is the second agreement that Affymetrix has made with HGSI to use its genetic sequence information in its GeneChip platform and it is another step in Affymetrix's continuing struggle to establish its GeneChip system as something of a standard for the acquiring and manipulation of genetic information.
With HGSI's valuable rights to several key bacterial genome sequences, Affymetrix will be in the position to turn out some highly useful and specialized arrays.
The shares of Human Genome Sciences (NASDAQ: HGSI) closed up 2.87 percent (= $0.74) at $26.51 on Friday.
"Lately, I've been investing in technology companies because many of them have extensive management ownership." Examples include JDS Uniphase (Nasdaq: JDSU), SDL (Nasdaq: SDLI), Human Genome (Nasdaq: HGSI) and IDEC Pharmaceuticals (Nasdaq: IDPH).
Tickers featured: AMGN, ATLN.VX, AUXL, AZN, BIIB, BMY, BSTC, CORT, DYAX, EXEL, FRX, GILD, GSK, HGSI, RDEA, REGN, SGEN, SGYP.PK, SNY, SVNT, TRGT.
LymphoStat-B (belimumab) is a fully human anti-BLyS monoclonal antibody licensed by CAT to HGSI. HGSI is developing LymphoStat-B as a potential treatment for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
His picks in the group included Human Genome Sciences (Nasdaq: HGSI), Millennium Pharmaceuticals (Nasdaq: MLNM) and Affymetrix (Nasdaq: AFFX).
Human Genome Sciences Inc (Nasdaq: HGSI) on Thursday announced that it has received an unsolicited proposal from GlaxoSmithKline plc (GSK) to acquire HGS for USD13.00 per share in cash.